Simplex Trading’s Applied Therapeutics APLT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-3,300
| Closed | -$330 | – | 8997 |
|
|
2025
Q4 | $330 | Buy |
3,300
+600
| +22% | +$381 | ﹤0.01% | 8210 |
|
|
2025
Q3 | $1K | Sell |
2,700
-25,800
| -91% | -$12.2K | ﹤0.01% | 8762 |
|
|
2025
Q2 | $8K | Buy |
+28,500
| New | +$11K | ﹤0.01% | 7438 |
|
|
2025
Q1 | – | Sell |
-32,500
| Closed | -$27K | – | 8451 |
|
|
2024
Q4 | $27K | Sell |
32,500
-57,300
| -64% | -$359K | ﹤0.01% | 6435 |
|
|
2024
Q3 | $763K | Buy |
89,800
+78,500
| +695% | +$463K | ﹤0.01% | 3174 |
|
|
2024
Q2 | $52K | Sell |
11,300
-7,200
| -39% | -$34.1K | ﹤0.01% | 6037 |
|
|
2024
Q1 | $125K | Buy |
18,500
+17,300
| +1,442% | +$77.7K | ﹤0.01% | 5351 |
|
|
2023
Q4 | $4K | Sell |
1,200
-2,800
| -70% | -$6.97K | ﹤0.01% | 7931 |
|
|
2023
Q3 | $9K | Hold |
4,000
| – | – | ﹤0.01% | 7218 |
|
|
2023
Q2 | $5K | Buy |
+4,000
| New | +$5.31K | ﹤0.01% | 7881 |
|
|
2022
Q4 | – | Sell |
-3,000
| Closed | -$2K | – | 9129 |
|
|
2022
Q3 | $2K | Buy |
+3,000
| New | +$3.6K | ﹤0.01% | 9222 |
|
|
2022
Q2 | – | Sell |
-1,100
| Closed | -$2K | – | 9876 |
|
|
2022
Q1 | $2K | Buy |
+1,100
| New | +$2.95K | ﹤0.01% | 9813 |
|
|
2021
Q4 | – | Sell |
-9,200
| Closed | -$198K | – | 10412 |
|
|
2021
Q3 | $198K | Hold |
9,200
| – | – | ﹤0.01% | 5595 |
|
|
2021
Q2 | $191K | Buy |
9,200
+9,199
| +919,900% | +$174K | ﹤0.01% | 5746 |
|
|
2021
Q1 | $1K | Buy |
+1
| New | +$22 | ﹤0.01% | 8529 |
|
Simplex Trading's APLT Position: Q4 2024 in Review
Simplex Trading sold out of Applied Therapeutics (APLT) in Q4 2024, closing a stake of 6,071 shares — an estimated $38.1K sold.
Simplex Trading first reported a position in APLT in Q4 2020 and held it in 11 quarters. The position peaked at $799K in Q4 2020. 118 funds tracked by Wall St. Rank hold APLT as of Q4 2024.
- Simplex Trading reported no remaining Applied Therapeutics position as of Q4 2024 after selling out during the quarter.
- Simplex Trading sold 6,071 Applied Therapeutics shares in Q4 2024, an estimated $38.1K.
- Simplex Trading first reported a position in Applied Therapeutics in Q4 2020 and held it in 11 quarters.
- Simplex Trading's Applied Therapeutics position peaked at $799K in Q4 2020.
- 118 funds tracked by Wall St. Rank held Applied Therapeutics as of Q4 2024.
Based on Simplex Trading's 13F filing for Q4 2024, filed 11 Feb 2025.